+36.1%
MRNA vs ENTG
+45.4%
-9.3%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | ENTG | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +2.2% | +3.2% | +4.8% |
| 7D | -1.1% | +1.2% | -2.3% | -1.5% |
| 30D | +126.1% | -12.9% | +139.0% | +133.5% |
| 3M | +190.0% | -3.1% | +193.1% | +175.2% |
| 6M | +157.2% | +21.0% | +136.2% | +117.5% |
| YTD | +388.2% | +67.0% | +321.2% | +255.3% |
| 1Y | +467.0% | +68.6% | +398.4% | +299.6% |
| 3Y | +36.1% | +48.6% | -12.6% | -12.9% |
| All | +36.1% | +45.4% | -9.3% | -12.9% |
Cumulative growth
Daily Returns
Daily percentage return beside ENTG.
Daily Out/Under-Performance
Portfolio return minus ENTG return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ENTG return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded ENTG wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling